Investor presentation ProstaLund AB
North Point Securities invites you to an investor presentation for ProstaLund AB ("ProstaLund") on Monday 12 June at 12:00 and 18:00.
The company is now carrying out a rights issue of approximately SEK 40.0 million to market its product range in Europe and later in the USA.
Notification
Participation at Riddargatan 13A or via live stream.
Registration takes place to:
The invitation to the live stream is distributed upon registration
The rights issue in brief
Subscription price: SEK 1.75 per share
Issue amount: SEK 40.0 million
Number of shares in the offer: 22,877,261
Record date: 26 May 223
Subscription period: 1 – 20 June 2023
Subscription obligations: Approximately SEK 14.8 million (37.1%)
Read more here!
ProstaLund in brief
ProstaLund is a Swedish company with headquarters in Lund. The company develops, markets and sells products in urology. The majority of sales are made through recurring sales of disposable catheters, antennas and other accessories that are used together with the Company's platform in the treatment of benign prostate enlargement.